SCHEMBL9891447

SCHEMBL9891447

COc1ccc(NCCCC(=O)OC(C)(C)C)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.53
GAA P10253 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.48
HDAC8 Q9BY41 5/20 0.46
ALDH1A1 P00352 3/20 0.46
HTT P42858 1/20 0.46
FFAR1 O14842 1/20 0.44
PPARG P37231 1/20 0.44
PTPN1 P18031 1/20 0.44
HDAC1 Q13547 4/20 0.43
HDAC3 O15379 3/20 0.43
HDAC2 Q92769 3/20 0.43
HDAC10 Q969S8 3/20 0.43
HDAC11 Q96DB2 3/20 0.43
HDAC6 Q9UBN7 3/20 0.43
HDAC5 Q9UQL6 3/20 0.43
HDAC4 P56524 2/20 0.43
HDAC7 Q8WUI4 2/20 0.43
HDAC9 Q9UKV0 2/20 0.43
PDK1 Q15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28471566 0.91 MAPT (0.56) MAPTGAAL3MBTL1HDAC8ALDH1A1
SCHEMBL9891440 0.89 HDAC8 (0.46) MAPTGAAHDAC8ALDH1A1PPARG
SCHEMBL11317810 0.86 MAPT (0.61) MAPTGAAL3MBTL1HDAC8ALDH1A1
SCHEMBL9891431 0.86 HDAC8 (0.44) MAPTGAAL3MBTL1HDAC8ALDH1A1
SCHEMBL9892810 0.86 POLB (0.54) MAPTL3MBTL1HDAC8ALDH1A1HTT
SCHEMBL9891433 0.85 HDAC8 (0.42) MAPTL3MBTL1HDAC8ALDH1A1HTT
SCHEMBL9891445 0.85 PDK1 (0.47) MAPTGAAHDAC8ALDH1A1HTT
SCHEMBL9891452 0.84 ALDH1A1 (0.48) MAPTHDAC8ALDH1A1HDAC1HDAC3
SCHEMBL16369813 0.83 POLB (0.42) MAPTHDAC8RAB9A
SCHEMBL9891441 0.83 POLB (0.42) MAPTL3MBTL1HDAC8ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8921026-B2 Basic compound, chemically amplified resist composition, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-12-30 US disclosed
US-20120141938-A1 BASIC COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120141938-A1 BASIC COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND PATTERNING PROCESS GABRA5, GABRB1, GABBR1 MAPT 2995/4885GAA 562/4885L3MBTL1 3900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.